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In Brief
Dahl et al. identify a new control mechanism that ensures that microtubule-organizing centers duplicate only once per cell cycle. A short alternative splice isoform of the centrosome protein, CEP135, represses centriole duplication. This centrosomelocalized isoform is controlled through the cell cycle to limit promiscuous centriole assembly.
SUMMARY
Centriole duplication is coordinated such that a single round of duplication occurs during each cell cycle. Disruption of this synchrony causes defects including supernumerary centrosomes in cancer and perturbed ciliary signaling [1] [2] [3] [4] [5] . To preserve the normal number of centrioles, the level, localization, and post-translational modification of centriole proteins is regulated so that, when centriole protein expression and/or activity are increased, centrioles self-assemble. Assembly is initiated by the formation of the cartwheel structure that comprises the base of centrioles [6] [7] [8] [9] [10] [11] . SAS-6 constitutes the cartwheel, and SAS-6 levels remain low until centriole assembly is initiated at S phase onset [3, 12, 13] . CEP135 physically links to SAS-6 near the site of microtubule nucleation and binds to CPAP for triplet microtubule formation [13, 14] . We identify two distinct protein isoforms of CEP135 that antagonize each other to modulate centriole duplication: full-length CEP135 (CEP135 full ) promotes new assembly, whereas a short isoform, CEP135 mini , represses it. CEP135 mini represses centriole duplication by limiting the centriolar localization of CEP135 full binding proteins (SAS-6 and CPAP) and the pericentriolar localization of g-tubulin. The CEP135 isoforms exhibit distinct and complementary centrosomal localization during the cell cycle. CEP135 mini protein decreases from centrosomes upon anaphase onset. We suggest that the decrease in CEP135 mini from centrosomes promotes centriole assembly. The repression of centriole duplication by a splice isoform of a protein that normally promotes it serves as a novel mechanism to limit centriole duplication.
RESULTS AND DISCUSSION
CEP135 is a microcephaly-associated (MCPH8), cartwheel protein that promotes centriole assembly and stability [9, 13, [15] [16] [17] [18] [19] . The protein contains a coiled-coil domain and conserved regions near the N terminus and the C terminus, respectively ( Figure 1A) . The CEP135 N terminus binds to microtubules and CPAP [13, 20] . The CEP135 C terminus binds to the cartwheel protein SAS-6 and maintains it at the cartwheel in Chlamydomonas [21] . Thus, CEP135 links the cartwheel with centriole triplet microtubule assembly, an early event in centriole biogenesis [13] . How CEP135 activity is regulated remains unclear [3] .
A Short Isoform of CEP135 Localizes to Centrioles and the PCM We identified an alternative splice isoform of human CEP135 (Figures 1A and S1A; CEP135 mini ). Intron 5 is retained in the mRNA of this short isoform, causing translation readthrough into the intron, thereby adding 16 amino acids followed by a stop codon to generate CEP135 mini . The 29-kDa CEP135 mini isoform contains the CEP135 N terminus required for microtubule binding but lacks the predicted CPAP-and SAS-6-binding domains found in the 134-kDa CEP135 full isoform [13, 16] . Both CEP135 full and CEP135 mini transcripts are detected in U2OS, RPE1, and HeLa cells ( Figure S1B ; data not shown). Affinity-purified antibodies that specifically recognize the CEP135 mini isoform were generated using two peptides containing amino acid sequences specific to CEP135 mini 's divergent C terminus (Figures 1 and S1 ). CEP135 mini localizes to centrosomes in RPE1, U2OS, and HeLa cells (Figures 1B-1F and S1; data not shown). Similar localization is found in cells expressing fluorescent protein fusions to CEP135 mini ( Figure S1I ).
CEP135
mini 's localization pattern changes through the cell cycle. During G1 phase of the cell cycle, CEP135 mini localizes predominantly to the proximal end of centrioles but is slightly spread compared to CEP135 full ( Figures 1B and S4C-S4F ), whereas in G2 it localizes both to centrioles and to the pericentriolar material (PCM) as judged by co-staining with g-tubulin ( Figures 1B, 1C , and S4D-S4F). CEP135 full localization to the PCM was not observed in either G1 or G2 ( Figures 1B, 1C , and S1I) [16, 20, [22] [23] [24] . Immuno-EM localization also places CEP135 mini at the proximal end of the centriole co-incident with the triplet microtubules and the PCM (Figures 1D-1F) . Thus, the CEP135 protein isoforms exhibit distinct localization patterns at the centrosome. Figure 2C ). These results confirm prior studies showing that CEP135 full promotes centriole assembly and that its levels must be controlled to limit centriole over-duplication [9, 13] . Conversely, CEP135 mini knockdown increases the number of cells with over-duplicated centrioles (Figures 2A and  2B ), whereas overexpression of CEP135 mini causes an increase in cells with under-duplicated centrioles ( Figure 2C ). These results suggest that CEP135 mini represses centriole assembly.
CEP135 mini knockdown was confirmed by measuring transcript and protein levels (Figures S1F, S1H, S2B, and S2C). All phenotypes were rescued by exogenous expression of siRNAimpervious mutants ( Figure S2D ). Finally, the CEP135 full and CEP135 mini knockdown had a minimal impact on the cell cycle ( Figure S2E ), suggesting that the phenotypes are not due to changes in the cell cycle or in aberrant cell divisions. We did observe a low level of multipolar mitoses upon CEP135 mini knockdown as is expected with centrosome amplification (data not shown). Together, the knockdown and overexpression experiments support a model in which CEP135 mini , in contrast to CEP135 full , negatively regulates centriole and centrosome duplication.
To determine whether CEP135 full and CEP135 mini perturbations affect centriole duplication independent of the cell cycle, we next examined whether these isoforms modulate aberrant Plk4-induced centriole amplification in S-phase-arrested RPE1 cells [8] [9] [10] [11] . Sixty-one percent of control cells that overexpress Plk4 over-duplicate their centrioles ( Figures 2D and 2E ). CEP135 full knockdown blocks Plk4-induced centriole over-duplication ( Figure 2E ), whereas CEP135 full overexpression moderately augments centriole over-duplication ( Figure 2G ) [9, 13] . In contrast, CEP135 mini knockdown moderately increases overduplication and also increases the total number of centrioles per cell ( Figure 2F ), whereas CEP135 mini overexpression dramatically reduces the number of cells with over-duplicated centrioles ( Figure 2G ). Concurrent knockdown of both isoforms partially rescues the loss in centriole over-duplication that is seen in CEP135 full -only knockdown ( Figure 2E ). A nearly identical trend was observed in S-phase-arrested U2OS cells that normally over-duplicate their centrioles ( Figure S2A ). Collectively, these results suggest that the balance between the CEP135 isoforms is important for the normal homeostasis of centriole numbers and that CEP135 mini counteracts CEP135 full function in promoting centriole duplication.
CEP135 mini Expression Limits the Centriolar Levels of Essential Assembly Factors
The negative effect of CEP135 mini on centriole duplication led us to ask whether CEP135 mini disrupts the ability of CEP135 full to promote centriole duplication. A simple explanation is that (B) Localization of centrin (a-Centrin; red), g-tubulin (a-g-Tub; green), CEP135 full (a-CEP135 full , green), and CEP135 mini (Alexa488-a-CEP135 mini ;
cyan and red) during G1. CEP135 Figure S3A ), suggesting that CEP135 full is able to localize to centrioles even when CEP135 mini levels are high.
An alternative possibility is that overexpressed CEP135 mini disrupts centriole duplication by binding to CEP135 full and precluding its association with its binding partners (SAS-6 and CPAP). To explore the potential interaction between the CEP135 isoforms, we took advantage of the ectopic cytoplasmic foci that CEP135 forms upon overexpression [13, 26] . Such foci are presumably the result of oligomerization of CEP135 protein. When both isoforms are expressed in RPE1 cells, ectopic foci that are not associated with centrosomes contain both CEP135 full and CEP135 mini . This suggests that CEP135 mini is competent to associate with CEP135 full ( Figure S3B ). We next asked whether CEP135 mini affects the localization of CEP135 full -binding proteins that function in centriole duplication (SAS-6 and CPAP). SAS-6-dependent cartwheel assembly initiates centriole biogenesis [12, [27] [28] [29] . Overexpression of CEP135 full and CEP135 mini decreases SAS-6 levels at centrioles by 48% and 44%, respectively ( Figure 3A) . The reduced SAS-6 levels are consistent with the loss of SAS-6 from centrioles in Chlamydomonas bld10 (CEP135) mutants and suggests that the interplay between SAS-6 and CEP135 full is important for new centriole biogenesis [13, 21] . Overexpressed CEP135 full protein binds SAS-6 and might sequester SAS-6 from the centriole ( Figure S3C ). In contrast, we speculate that CEP135 mini , which only weakly and variably interacts with SAS-6, promotes a cartwheel conformation that disrupts SAS-6 localization to the centriole ( Figure S3C ). We next assessed whether the centriolar localization of the CEP135 full -binding protein and centriole duplication factor, CPAP, is affected by CEP135 isoform levels [9, 13, 30] . CEP135 full overexpression modestly reduces centriolar CPAP localization ( Figure 3B ), which we predict is because expressed CEP135 full binds to and sequesters CPAP to the cytoplasm ( Figure S3D ). Conversely, CEP135 mini , which does not interact with CPAP, exhibits a potent inhibitory effect on CPAP full causes a moderate increase in the number of cells with amplified centrioles (64% ± 5% versus 80% ± 7%), whereas CEP135 mini overexpression represses centriole amplification (64% ± 5% versus 6% ± 6%). Mean ± SD represents three separate experiments. See also Figure S2 . localization ( Figure S3D ). This may allow CEP135 mini to selectively inhibit centriole duplication. Collectively, our data suggest that CEP135 mini prevents centriole duplication by limiting CEP135 full -interacting, centriole assembly factors from associating with the centriole.
The PCM network of proteins surrounding centrioles is organized into distinct functional domains [31] [32] [33] [34] . The PCM is required for centriole biogenesis, and CPAP is important for PCM organization [27, [35] [36] [37] . The PCM establishes a nucleation domain from which nascent centrioles are built, beginning with the cartwheel [31] [32] [33] [34] . Overexpression of CEP135 mini , but not CEP135 full , causes a 56% decrease in g-tubulin from the PCM ( Figure 3C ). Thus, CEP135 mini overexpression causes loss of both centriolar (SAS-6 and CPAP) and PCM (g-tubulin) components, suggesting that it regulates multiple facets of centriole and centrosome biogenesis.
CEP135 Isoforms Localize in a Cell-Cycle-Dependent Manner
The antagonistic functions of the CEP135 isoforms suggest that their centriolar levels and localization are modulated through the cell cycle to promote centriole assembly only during G1/S phase of the cell cycle. To test this, we staged cycling cells and examined the centriolar level of the CEP135 isoforms. CEP135 full levels are high during centriole duplication at the G1/S phase boundary ( Figure 4A ). Effectively one half of the total CEP135 full protein is predicted to be associated with each G1 centriole or new centriole pair following S phase. These levels increase by 15% through metaphase of mitosis ( Figure 4A ) and then increase further (11%) by telophase ( Figure 4C ). Consistent with a role for CEP135 mini in repressing centriole assembly, CEP135 mini protein levels are lowest during G1/S when centrioles duplicate. After centriole duplication, the centriolar levels of CEP135 mini increase and peak at metaphase of mitosis. Because CEP135 mini overexpression decreases g-tubulin levels at the centrosome ( Figure 3C ), the high mitotic CEP135 mini levels are inconsistent with the high g-tubulin levels found at mitotic centrosomes [38] . Perhaps the CEP135 mini overexpression results represent non-physiological CEP135 mini activity. Alternatively, CEP135 mini may normally control g-tubulin recruitment to the centrosome. In summary, at G1/S, CEP135 full levels are high and CEP135 mini levels are low to promote new centriole biogenesis, whereas CEP135 mini increases through the remainder of the cell cycle until metaphase, perhaps to repress promiscuous centriole duplication and PCM expansion. Centrin localizes to the distal end of centrioles, allowing us to determine the sub-centrosomal localization of the CEP135 isoforms during the cell cycle ( Figures 4B and S4C ) [39] . As expected, CEP135 full localizes at the proximal end of the two centrioles during G1 and at the mother centrioles during S phase. Consistent with previous reports, CEP135 full is not detectable at daughter centrioles until G2 [34] . Maturation of the daughter centriole is accompanied by a slow accumulation of CEP135 full so that protein levels are once again high by the G1/S phase boundary of the following cell cycle. Additionally, we propose that CEP135 full at the mother centriole is important for nucleation of the daughter centriole as is shown for SAS-6 [40, 41] .
Unlike CEP135 full , CEP135 mini localizes to the proximal end of the centriole during G1 and, upon progression into the cell cycle, becomes increasingly associated with the PCM (Figures 4B  and S4D-S4F ). This redistribution of CEP135 mini to the PCM may position CEP135 mini to suppress CEP135 full -dependent centriole biogenesis by limiting CEP135 full 's association with its binding partners. However, the function of the unique localization between the two CEP135 isoforms remains to be discovered. Upon transit from metaphase into the subsequent G1, CEP135 mini levels drop. Consistent with the CEP135 mini protein decrease, CEP135 mini transcript levels also decrease during mitosis ( Figure S4A ). We suggest this decrease permits centriole assembly.
Conclusions
We discovered a CEP135 splice isoform, CEP135 mini , which limits centriole duplication ( Figure 4D) See also Figure S4 .
